Highly specific in vivo gene delivery for p53-mediated apoptosis and genetic photodynamic therapies of tumour

Nature Communications

Volumn 6, Issue , 2015, Pages

  Tseng, S Ja ^a   Liao, Zi Xian ^b   Kao, Shih Han ^c   Zeng, Yi Fang ^d   Huang, Kuo Yen ^e   Li, Hsin Jung ^f   Yang, Chung Lin ^g   Deng, Yu Fan ^h   Huang, Chi Feng ⁱ   Yang, Shuenn Chen ^d   Yang, Pan Chyr ^a,d,i   Kempson, Ivan M ^j  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL SUN YAT SEN UNIVERSITY   (Taiwan)

^c CHINA MEDICAL UNIVERSITY   (Taiwan)

^d NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^e NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

^f CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^g CHUNG YUAN CHRISTIAN UNIVERSITY   (Taiwan)

^h INSTITUTE OF PHYSICS   (Taiwan)

ⁱ INSTITUTE OF BIOMEDICAL SCIENCES   (Taiwan)

^j UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

more..

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53; REACTIVE OXYGEN METABOLITE; 3-AMINOGLUTARIC ACID; 4',6 DIAMIDINO 2 PHENYLINDOLE; DIMETHYL SULFOXIDE; GLUTAMIC ACID DERIVATIVE; GREEN FLUORESCENT PROTEIN; INDOLE DERIVATIVE; KILLER RED PROTEIN, ANTHOMEDUSAE;

APOPTOSIS; GENE EXPRESSION; PH; PHYSICOCHEMICAL PROPERTY; POLYMER; PROTEIN; TUMOR;

ANIMAL CELL; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; CANCER GENE THERAPY; CANCER INHIBITION; CONTROLLED STUDY; ENDOSOME; FEMALE; GENE TARGETING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IN VIVO GENE TRANSFER; IN VIVO STUDY; INTERNALIZATION; MOUSE; NON SMALL CELL LUNG CANCER; NONHUMAN; PH; PHOTODYNAMIC THERAPY; PROTEIN EXPRESSION; RADIOSENSITIZATION; TREATMENT RESPONSE; TUMOR MICROENVIRONMENT; ANIMAL; BAGG ALBINO MOUSE; CARCINOMA, NON-SMALL-CELL LUNG; GENE TRANSFER; METABOLISM; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PHOTOCHEMOTHERAPY; PHYSIOLOGY; PROCEDURES; TUMOR CELL LINE; TUNEL ASSAY;

ANIMALIA;

ANIMALS; APOPTOSIS; CARCINOMA, NON-SMALL-CELL LUNG; CELL LINE, TUMOR; DIMETHYL SULFOXIDE; ENDOSOMES; GENE TRANSFER TECHNIQUES; GLUTAMATES; GREEN FLUORESCENT PROTEINS; HUMANS; HYDROGEN-ION CONCENTRATION; IN SITU NICK-END LABELING; INDOLES; MAGNETIC RESONANCE SPECTROSCOPY; MICE; MICE, INBRED BALB C; PHOTOCHEMOTHERAPY; TUMOR MICROENVIRONMENT; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84924347681     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms7456     Document Type: Article

References (40)

1. Hollstein, M., Sidransky, D., Vogelstein, B. & Harris, C. C. p53 mutations in human cancers. Science 253, 49-53 (1991).
2. Hoe, K. K., Verma, C. S. & Lane, D. P. Drugging the p53 pathway: understanding the route to clinical efficacy. Nat. Rev. Drug Discov. 13, 217-236 (2014).
3. Brosh, R. & Rotter, V. When mutants gain new powers: news from the mutant p53 field. Nat. Rev. Cancer 9, 701-713 (2009).
4. Prabha, S., Sharma, B. & Labhasetwar, V. Inhibition of tumor angiogenesis and growth by nanoparticle-mediated p53 gene therapy in mice. Cancer Gene Ther. 19, 530-537 (2012).
5. Nemunaitis, J. et al. Biomarkers predict p53 gene therapy efficacy in recurrent squamous cell carcinoma of the head and neck. Clin. Cancer Res. 15, 7719-7725 (2009).
6. Senzer, N. et al. p53 therapy in a patient with Li-Fraumeni syndrome. Mol. Cancer Ther. 6, 1478-1482 (2007).
7. Senzer, N. et al. Phase I study of a systemically delivered p53 nanoparticle in advanced solid tumors. Mol. Ther. 21, 1096-1103 (2013).
8. Wang, S. P. et al. p53 controls cancer cell invasion by inducing the MDM2-mediated degradation of Slug. Nat. Cell Biol. 11, 694-704 (2009).
9. Johnson, T. M., Yu, Z. X., Ferrans, V. J., Lowenstein, R. A. & Finkel, T. Reactive oxygen species are downstream mediators of p53-dependent apoptosis. Proc. Natl Acad. Sci. USA 93, 11848-11852 (1996).
10. Seoane, J., Le, H. V. & Massagué, J. Myc suppression of the p21(Cip1) Cdk inhibitor influences the outcome of the p53 response to DNA damage. Nature 419, 729-734 (2002).
11. Gogna, R., Madan, E., Kuppusamy, P. & Pati, U. Reactive oxygen speciesmediated p53 core-domain modifications determine apoptotic or necrotic death in cancer cells. Antioxid. Redox Signal 16, 400-412 (2012).
12. Polyak, K., Xia, Y., Zweier, J. L., Kinzler, K. W. & Vogelstein, B. A model for p53-induced apoptosis. Nature 389, 300-305 (1997).
13. Rivera, A. & Maxwell, S. A. The p53-induced gene-6 (proline oxidase) mediates apoptosis through a calcineurin-dependent pathway. J. Biol. Chem. 280, 29346-29354 (2005).
14. Yousefi, A., Storm, G., Schiffelers, R. & Mastrobattista, E. Trends in polymeric delivery of nucleic acids to tumors. J. Control. Release 170, 209-218 (2013).
15. Bulina, M. E. et al. A genetically encoded photosensitizer. Nat. Biotechnol. 24, 95-99 (2006).
16. Liao, Z. X., Li, Y. C., Lu, H. M. & Sung, H. W. A genetically-encoded KillerRed protein as an intrinsically generated photosensitizer for photodynamic therapy. Biomaterials 35, 500-508 (2014).
17. Moore, C. M., Pendse, D. & Emberton, M. Photodynamic therapy for prostate cancer - a review of current status and future promise. Nat. Rev. Urol. 6, 18-30 (2009).
18. Chen, J. et al. In vitro and in vivo gene delivery using polyethyleniminepoly(hydroxyethyl glutamine) as a non-viral carrier. J. Control. Release 152(Suppl 1): e134-e136 (2011).
19. Liao, Z. X. et al. Enhancement of efficiencies of the cellular uptake and gene silencing of chitosan/siRNA complexes via the inclusion of a negatively charged poly(gamma-glutamic acid). Biomaterials 31, 8780-8788 (2010).
20. Lin, C. W. et al. Extracellular delivery of modified oligonucleotide and superparamagnetic iron oxide nanoparticles from a degradable hydrogel triggered by tumor acidosis. Biomaterials 34, 4387-4393 (2013).
21. Yoo, J. W., Irvine, D. J., Discher, D. E. & Mitragotri, S. Bio-inspired, bioengineered and biomimetic drug delivery carriers. Nat. Rev. Drug Discov. 10, 521-535 (2011).
22. Zeng, Y. F. et al. Controlled delivery of recombinant adeno-associated virus serotype 2 using pH-sensitive poly(ethylene glycol)-poly-L-histidine hydrogels. Biomaterials 33, 9239-9245 (2012).
23. Helmlinger, G., Yuan, F., Dellian, M. & Jain, R. K. Interstitial pH and pO2 gradients in solid tumors in vivo: high-resolution measurements reveal a lack of correlation. Nat. Med. 3, 177-182 (1997).
24. Tseng, S. J. et al. Switchable delivery of small interfering RNA using a negatively charged pH-responsive polyethylenimine-based polyelectrolyte complex. Chem. Commun. 49, 2670-2672 (2013).
25. Tseng, S. J. et al. Environment acidity triggers release of recombinant adeno-associated virus serotype 2 from a tunable matrix. J. Control. Release 170, 252-258 (2013).
26. Moghimi, S. M. et al. A two-stage poly(ethylenimine)-mediated cytotoxicity: implications for gene transfer/therapy. Mol. Ther. 11, 990-995 (2005).
27. Ndoye, A. et al. Eradication of p53-mutated head and neck squamous cell carcinoma xenografts using nonviral p53 gene therapy and photochemical internalization. Mol. Ther. 13, 1156-1162 (2006).
28. Li, D. et al. Construction of a star-shaped copolymer as a vector for FGF receptor-mediated gene delivery in vitro and in vivo. Biomacromolecules 11, 2221-2229 (2010).
29. Xu, L. & Anchordoquy, T. Drug delivery trends in clinical trials and translational medicine: challenges and opportunities in the delivery of nucleic acid-based therapeutics. J. Pharm. Sci. 100, 38-52 (2011).
30. Ventura, A. et al. Restoration of p53 function leads to tumour regression in vivo. Nature 445, 661-665 (2007).
31. Rubin, A. I., Chen, E. H. & Ratner, D. Basal-Cell Carcinoma. N. Engl. J. Med. 353, 2262-2269 (2005).
32. Rigual, N. et al. Photodynamic therapy with 3-(10-hexyloxyethyl) pyropheophorbide a for cancer of the oral cavity. Clin. Cancer Res. 19, 6650-6613 (2013).
33. Prout, G. R. et al. Photodynamic therapy with hematoporphyrin derivative in the treatment of superficial transitional-cell carcinoma of the bladder. N. Engl. J. Med. 317, 1251-1255 (1987).
34. Barathan, M. et al. Hypericin-photodynamic therapy leads to interleukin-6 secretion by HepG2 cells and their apoptosis via recruitment of BH3 interacting-domain death agonist and caspases. Cell Death Dis. 4, e697 (2013).
35. Huggett, M. T. et al. Phase I/II study of verteporfin photodynamic therapy in locally advanced pancreatic cancer. Br. J. Cancer 110, 1698-1704 (2014).
36. Spechler, S. J. & Souza, R. F. Barrett's esophagus. N. Engl. J. Med. 371, 836-845 (2014).
37. Akopov, A. et al. Preoperative endobronchial photodynamic therapy improves resectability in initially irresectable (inoperable) locally advanced non small cell lung cancer. Photodiagnosis Photodyn. Ther. 11, 259-264 (2014).
38. Ross, P. et al. Incorporation of photodynamic therapy as an induction modality in non-small cell lung cancer. Lasers Surg. Med. 38, 881-889 (2006).
39. Cai, X. J. et al. Photodynamic therapy for intractable bronchial lung cancer. Photodiagnosis Photodyn. Ther. 10, 672-676 (2013).
40. Begg, A. C., Stewart, F. A. & Vens, C. Strategies to improve radiotherapy with targeted drugs. Nat. Rev. Cancer 11, 239-253 (2011).